Serra Hyundai Offers Customers its Fresh Start Finance Program
BIRMINGHAM, Ala. (PRWEB) January 29, 2020
Serra Hyundai of the Steve Serra Auto Group is offering its customers financing options through the Fresh Start Financing program. Shoppers that visit the dealership for a new or used vehicle can receive financing options that meet their needs. Serra Hyundai provides credit options to local residents with any type of credit history or budget.
The financing process is completely confidential. The financing team uses the non-invasive process of soft-credit checks to determine the best car loan for the person's budget. Serra Hyundai will help any customer including those who have gone through divorce or bankruptcy. Interested parties must fill out the secure and confidential credit application online to apply for financing. After the application has been filled out and received, a finance team member will work with the customer to create a finance plan.
Once a credit application goes through and a finance plan has been figured out, applicants can start shopping the Serra Hyundai new and used inventory. Serra Hyundai offers vehicles for families, new drivers or commuters. Shoppers can see the inventory in person at the dealership or online from their phone, tablet or computer.
If customers would like to learn more about Fresh Start Financing, they can find more information at serrahyundai.com. They can also contact the dealership at 205-304-0929. Serra Hyundai is open Monday-Friday from 7 a.m. to 7:30 p.m. and on Saturday from 8 a.m. to 7:30 p.m.
Read the full story at https://www.prweb.com/releases/serra_hyundai_offers_customers_its_fresh_start_finance_program/prweb16865553.htm
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
- Skanska signs additional contract for new hospital in Fort Myers, Florida, USA, for USD 60M, about SEK 560M
- Ultragenyx Announces Marketing Authorisation Application (MAA) Submission to the European Medicines Agency (EMA) for the First Investigational Gene Therapy for MPS IIIA (Sanfilippo Syndrome Type A)
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share